| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Revenue | $171.7M | +39.2% |
| Cost of Revenue | $128.7M | +38.7% |
| Gross Profit | $43.0M | +41.0% |
| R&D Expense | $288K | -36.7% |
| SG&A Expense | $35.6M | +41.4% |
| Operating Income | $7.1M | +45.8% |
| Pre-tax Income | $6.9M | +45.6% |
| Income Tax | $1.6M | +57.3% |
| Net Income | $5.3M | +42.4% |
| EPS (Basic) | $0.14 | +40.0% |
| EPS (Diluted) | $0.13 | +44.4% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.0M | +179.0% |
| Accounts Receivable | $13.1M | +60.8% |
| Inventory | $9.6M | +100.3% |
| Current Assets | $45.1M | +106.1% |
| Total Assets | $85.7M | +82.1% |
| Current Liabilities | $20.8M | +22.0% |
| Long-term Debt | $5.6M | — |
| Total Liabilities |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $11.4M | +120.6% |
| Capital Expenditures | $1.7M | -67.5% |
| Investing Cash Flow | -$19.0M | -272.2% |
| Financing Cash Flow | $20.3M | +614.5% |
| Free Cash Flow | $9.8M | — |
| $33.1M |
| +49.2% |
| Stockholders' Equity | $52.6M | +111.4% |